Proteomic Profiling Captures Residual Cardiovascular Risk Beyond the PREVENT Model in Individuals With
Xuefei Han1,2, Jiacheng Ding2,3, Jingqian Li2,3
1Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China.
A new protein risk score (PRS) improves cardiovascular disease (CVD) prediction in patients with cardiovascular-kidney-metabolic (CKM) syndrome Stages 2-3. This PRS, combined with the PREVENT model, enhances risk stratification for better management.
Area of Science:
- Biochemistry and Molecular Biology
- Cardiology
- Nephrology
- Metabolic Syndrome Research
Background:
- Cardiovascular-kidney-metabolic (CKM) syndrome involves complex interactions between metabolic disorders, kidney injury, and cardiovascular disease (CVD).
- Stages 2 and 3 of CKM syndrome are critical progression phases with significant pathological heterogeneity.
- Existing risk prediction models may not fully capture the complex risk in this population.
Purpose of the Study:
- To develop a novel protein risk score (PRS) for predicting CVD events in individuals with CKM Stages 2-3.
- To evaluate the incremental predictive value of this PRS when added to the established PREVENT model.
- To improve risk stratification and management strategies for high-risk CKM patients.
Main Methods:
- Utilized data from 24,017 UK Biobank participants with CKM Stages 2-3.
- Developed a PRS using 2923 plasma proteins and the LASSO method in a training set (n=19,218).
- Validated the PRS in an independent set (n=4799), assessing its performance with C-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) against the PREVENT model.
Main Results:
- A 63-protein PRS was constructed, reflecting inflammation, kidney injury, and matrix remodeling pathways.
- Key proteins included GDF15, HAVCR1, MMP12, and NT-proBNP.
- The PRS significantly improved CVD prediction: high PRS group had 2.56-fold higher CVD risk; C-statistic increased by 0.034; 10-year NRI was 15.8%; IDI was 2.2% when integrated with the PREVENT model.
Conclusions:
- The developed PRS effectively enhances CVD event prediction in the CKM Stages 2-3 population.
- Integrating the PRS with the PREVENT model captures residual risk, enabling more precise patient stratification.
- This combined approach supports tailored management strategies for individuals at high risk within the CKM syndrome spectrum.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
